Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Beyond Air, Inc. (XAIR)

$5.61 -2.77% NASDAQ: XAIR · 15-min delayed
  • GARDEN CITY, New York
  • Public · NASDAQ: XAIR
  • 61 employees
$5.2MMarket cap
$3.7MRevenue · FY2025
-$46.6MNet income
61Employees
XAIRNASDAQ
2016IPO

About Beyond Air, Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$3.7M
Net income
-$46.6M
Total assets
$30.1M
Market cap
$5.2M
Gross margin
3.3%
Operating margin
-378.2%
Net margin
-447.1%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2026

Financial statements

Income statement

Revenue
$7.7M
Cost of revenue
$7.4M
Gross profit
$252.0K
Operating expenses
$29.3M
Operating income
-$29.0M
Net income
-$34.3M
EPS (basic)
$-4.01
EPS (diluted)
$-4.01

Balance sheet

Total assets
$35.4M
Current assets
$24.8M
Total liabilities
$29.2M
Current liabilities
$6.5M
Shareholders’ equity
$6.2M

Cash flow

Operating cash flow
-$18.1M
Investing cash flow
-$3.7M
Financing cash flow
$29.1M
Net cash flow
$7.3M

Statements via Polygon.io (SEC filings)

NASDAQ: XAIR
$5.61 -2.77%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.61 $114.00

52-week range

Market cap
$5.2M
EPS (diluted)
$-4.01
Shares outstanding
934.0K
Open
Day range
Prev close
Volume
IPO date
Apr 27, 2016

Beyond Air, Inc. (XAIR) Stock Price

  • Reported a net loss of $46.6M in FY2025.
  • Gross margin of 3.3%, net margin -447.1%.
  • Trading 95% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Beyond Air, Inc..

Write a review
Newsroom

News about Beyond Air, Inc.

News & sentiment via Polygon.io

FAQ

Beyond Air, Inc.: frequently asked questions

Is Beyond Air, Inc. an American company?

Beyond Air, Inc. is a US-based company headquartered in Garden City, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Beyond Air, Inc. headquartered?

Beyond Air, Inc. is headquartered in Garden City, New York, United States.

Is Beyond Air, Inc. publicly traded?

Yes — Beyond Air, Inc. is a publicly traded company. Its stock trades under the ticker symbol XAIR on the NASDAQ.

What does Beyond Air, Inc. do?

Beyond Air, Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →